Cargando…

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria

Detalles Bibliográficos
Autor principal:	Staevska, Maria T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135004/ https://www.ncbi.nlm.nih.gov/pubmed/27932886 http://dx.doi.org/10.2147/TCRM.S120628

Ejemplares similares

Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
por: Sánchez-Borges, Mario, et al.
Publicado: (2014)

Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria
por: Godse, Kiran, et al.
Publicado: (2016)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
por: Shah, Bela, et al.
Publicado: (2022)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety
por: Anuradha, P., et al.
Publicado: (2010)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

Desloratadine Efficacy in Relation to GSTM1 and GSTT1 Polymorphic Genes in Chronic Spontaneous Urticaria
por: Maouia, Amal, et al.
Publicado: (2022)

Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
por: Nettis, E, et al.
Publicado: (2008)

An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria
por: Sil, Amrita, et al.
Publicado: (2021)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
por: De, Abhishek, et al.
Publicado: (2021)

High-dose levocetirizine for the treatment of refractory chronic spontaneous urticaria and the effect on the serum inositol triphosphate level
por: Huang, Xianqiong, et al.
Publicado: (2019)

Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based Study
por: Kim, Harold, et al.
Publicado: (2008)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Efficiency and safety of desloratadine in combination with compound glycyrrhizin in the treatment of chronic urticaria: a meta-analysis and systematic review of randomised controlled trials
por: Wen, Yulong, et al.
Publicado: (2021)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
por: Fukunaga, Atsushi, et al.
Publicado: (2020)

Desloratadine Induced Pill Esophagitis
por: Alkim, Huseyin, et al.
Publicado: (2012)

Efficacy of Fangfeng Tongsheng Granule Combined with Levocetirizine in the Treatment of Chronic Urticaria and Its Effect on Serum Complement, IL-4, IgE, and IFN-γ Levels in Patients
por: Xu, Duanni, et al.
Publicado: (2022)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Efficacy of levocetirizine in isolated rat tracheal smooth muscle
por: Chou, Ying-Liang, et al.
Publicado: (2023)

Effectiveness and Safety of the Combination of the Traditional Chinese Medicine Prescription Jade Screen and Desloratadine in the Treatment of Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yuan, Shao-fei, et al.
Publicado: (2017)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Night-time sedating H(1)-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial
por: Staevska, M, et al.
Publicado: (2014)

Fixed drug eruption due to levocetirizine
por: Jhaj, Ratinder, et al.
Publicado: (2016)

Fixed Drug Eruption to Levocetirizine and Cetirizine
por: Gupta, Lalit Kumar, et al.
Publicado: (2014)

Fixed Drug Eruption Induced by Levocetirizine
por: An, Isa, et al.
Publicado: (2017)

Idiosyncratic Liver Injury Due to Levocetirizine
por: Annunziata, Giuseppe, et al.
Publicado: (2019)

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild‐to‐moderate asthma. The SKY study
por: Lavorini, Federico, et al.
Publicado: (2019)

Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2
por: Bhattacharyya, Dipankar
Publicado: (2020)

Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect
por: Slevogt, Hortense, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ljo4ojvubhro8jn312suv5ipc2